Activation of B2 bradykinin receptors by neurotensin

Cellular Signalling

Volumn 15, Issue 5, 2003, Pages 519-527

  Park, Tae Ju ^a   Kim, Kyong Tai ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

B2 bradykinin receptors; Neurotensin; Phospholipase C; Xenopsin

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE; NEUROTENSIN; NORADRENALIN; PHOSPHOLIPASE C; SR 486692;

ANIMAL CELL; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL LINE; CONTROLLED STUDY; CYTOSOL; ENZYME SYNTHESIS; HORMONE RELEASE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR BINDING;

EID: 0037400762     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(02)00136-5     Document Type: Article

References (37)

1. Carraway R., Leeman S.E. J. Biol. Chem. 248:1973;6854-6861.
2. Kitabgi P., Carraway R.E., Leeman S.E. J. Biol. Chem. 251:1976;7053-7058.
3. Vincent J.P. Cell. Mol. Neurobiol. 15:1995;501-512.
4. Vincent J.P., Mazella J., Kitabgi P. Trends Pharmacol. Sci. 20:1999;302-309.
5. McMahon B.M., Boules M., Warrington L., Richelson E. Life Sci. 70:2002;1101-1119.
6. Mazella J., Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M.et al. J. Biol. Chem. 273:1998;26273-26276.
7. Okuma Y., Osumi Y. Life Sci. 230:1982;77-84.
8. Okuma Y., Fukuda Y., Osumi Y. Eur. J. Pharmacol. 93:1983;27-33.
9. Bunn S.J., Marley P.D., Livett B.G. Neuropeptides. 15:1990;187-194.
10. Faggin B.M., Cubeddu L.X. J. Pharmacol. Exp. Ther. 253:1990;812-818.
11. Tischler A.S., Ruzicka L.A., DeLellis R.A. Neuroscience. 43:1991;671-678.
12. Tischler A.S., Ruzicka L.A., Dobner P.R. J. Biol. Chem. 266:1991;1141-1146.
13. Fischer-Colbrie R., Eskay R.L., Eiden L.E., Maas D. J. Neurochem. 59:1992;780-783.
14. Park T.J., Shin S.Y., Suh B.C., Suh E.K., Lee I.S., Kim Y.S.et al. Synapse. 29:1998;248-256.
15. Greene L.A., Sobeih M.M., Teng K.K. Banker G., Goslin K. Culturing nerve cells. 1991;207-226 MIT Press, Cambridge.
16. Suh B.C., Park T.J., Kim K.T. Eur. J. Pharmacol. 314:1996;235-242.
17. Park T.J., Song S.K., Kim K.T. J. Neurochem. 68:1997;2177-2185.
18. Park T.J., Chung S., Han M.K., Kim U.H., Kim K.T. J. Neurochem. C71:1998;1251-1260.
19. Nardone J., Gerald C., Rimawi L., Song L., Hogan P.G. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4412-4416.
20. Suh B.C., Kim K.T. Biochem. Pharmacol. 47:1994;1262-1266.
21. Suh B.C., Lee C.O., Kim K.T. J. Neurochem. 64:1995;1071-1079.
22. Amar S., Kitabgi P., Vincent J.P. J. Neurochem. 49:1987;999-1006.
23. Bozou J.C., Rochet N., Magnaldo I., Vincent J.P., Kitabgi P. Biochem. J. 264:1989;871-878.
24. Suh B.C., Kim K.T. J. Neurochem. 65:1995;2124-2130.
25. Clapham D.E. Neuron. 16:1996;1069-1072.
26. Yamada M., Yamada M., Watson M.A., Richelson E. Mol. Pharmacol. 46:1994;470-476.
27. Bozou J.C., Amar S., Vincent J.P., Kitabgi P. Mol. Pharmacol. 29:1986;489-496.
28. Owen P.J., Plevin R., Boarder M.R. J. Pharmacol. Exp. Ther. 248:1989;1231-1236.
29. Purkiss J.R., Nahorski S.R., Willars G.B. J. Neurochem. 64:1995;1175-1182.
30. Mazella J., Chabry J., Zsurger N., Vincent J.P. J. Biol. Chem. 264:1989;5559-5563.
31. Tanaka K., Masu M., Nakanishi S. Neuron. 4:1990;847-854.
32. Rioux F., Quirion R., Regoli D., Leblanc M.A., St-Pierre S. Eur. J. Pharmacol. 66:1980;273-279.
33. Vita Vita N., Laurent P., Lefort S., Chalon P., Lelias J.M., Kaghad M.et al. FEBS Lett. 317:1993;139-142.
34. Graness A., Adomeit A., Ludwig B., Muller W.D., Kaufmann R., Liebmann C. Biochem. J. 327:1997;147-154.
35. Hur E.M., Kim K.T. Cell. Signal. 14:2002;397-405.
36. Seguin L., Widdowson P.S., Giesen-Crouse E. J. Neurochem. 59:1992;2125-2133.
37. Seguin L., Widdowson P.S. J. Neurochem. 60:1993;752-757.